Chenyan Wu is currently the Study Director and Head of the mast cell platform at GENOSKIN, where they focus on innovative non-clinical immunoprofiling testing to advance drug and therapeutic development. Previously, Chenyan was a postdoctoral student at Karolinska Institutet, having also completed their PhD in Medicine at the same institution. Chenyan earned a Master’s degree in Oncology and Cancer Biology from Sun Yat-sen University and a Bachelor’s degree in Clinical Medicine from Southern Medical University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices